Edition:
United Kingdom

Alibaba Health Information Technology Ltd (0241.HK)

0241.HK on Hong Kong Stock

6.79HKD
23 May 2018
Change (% chg)

HK$0.86 (+14.50%)
Prev Close
HK$5.93
Open
HK$5.96
Day's High
HK$7.00
Day's Low
HK$5.87
Volume
124,498,486
Avg. Vol
15,142,935
52-wk High
HK$7.00
52-wk Low
HK$3.26

Latest Key Developments (Source: Significant Developments)

Alibaba Health Information Technology Updates On Agency Agreement
Friday, 20 Apr 2018 

April 20 (Reuters) - Alibaba Health Information Technology Ltd <0241.HK>::ALIBABA HEALTH (HK) ENTERS SECOND RENEWED AGENCY AGREEMENT, TERM STARTING FROM APRIL AND ENDING ON MARCH 2019.TOTAL INCENTIVE FEES TO BE RECEIVED BY ALIBABA HEALTH GROUP UNDER DEAL FOR FY19 WILL NOT BE MORE THAN RMB8 MILLION.  Full Article

Alibaba Health Information Technology Says Wang Lei Resigned As CEO
Thursday, 29 Mar 2018 

March 29 (Reuters) - Alibaba Health Information Technology Ltd <0241.HK>::WANG LEI RESIGNED AS CHIEF EXECUTIVE OFFICER.SHEN DIFAN APPOINTED CHIEF EXECUTIVE OFFICER.SHEN DIFAN APPOINTED AS EXECUTIVE DIRECTOR.  Full Article

Alibaba Health Information Technology Expects To Supply Products To Alibaba Group Of Not More Than RMB23 Million
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Alibaba Health Information Technology Ltd <0241.HK>::ALIBABA HEALTH INFORMATION TECHNOLOGY - EXPECTS TO SUPPLY PRODUCTS TO ALIBABA GROUP DURING YEAR ENDED MAR, 2018 OF NOT MORE THAN RMB23 MILLION.  Full Article

Alibaba Health Information Technology to issue shares to Ali JK Nutritional Products Holding
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Alibaba Health Information Technology Ltd <0241.HK>:Co & Ali JK Nutritional Products Holding ​enter subscription agreement of 442.4 million shares at HK$4 per share.Net proceeds of subscription, after deduction of related expenses, will be about HK$1.77 billion​.  Full Article

Alibaba Health Information Technology updates on Tmall services agreement<0241.HK>
Tuesday, 16 Aug 2016 

Alibaba Health Information Technology Ltd <0241.HK>: Expects commissions paid by gwqnp to tmall entities under agreement during term of tmall services agreement will not exceed hk$9 million . Refers to announcement in relation to acquisition of a 100% equity interest in Guangzhou Wu Qian Nian Pharmaceutical chain .  Full Article

Alibaba Health Information Technology notes decision of CFDA regarding amendments<0241.HK>
Thursday, 21 Jul 2016 

Alibaba Health Information Technology Ltd <0241.HK>: Voluntary announcement update in relation to the drug piats business . Notes decision of China FDA regarding amendment of good supply practice for pharmaceutical products . Says company does not expect to generate further revenue other than deferred revenue from operation of drug PIATS . Decision of China FDA regarding amendment will not have significant impact on co's business revenue as a whole .  Full Article

Alibaba Health Information Technology updates on acquisition of Guangzhou Wu Qian Nian Pharmaceutical Chain<0241.HK>
Wednesday, 6 Jul 2016 

Alibaba Health Information Technology Ltd <0241.HK>: Discloseable transaction <0241.HK> . Alibaba Health Technology (Beijing) entered into the acquisition agreement . Alibaba Health Technology shall acquire 100% equity interest in Guangzhou Wu Qian Nian Pharmaceutical Chain . Deal for a consideration of RMB16.8 million .  Full Article

Alibaba Health Information Technology says FY net loss RMB191.6 mln<0241.HK>
Wednesday, 22 Jun 2016 

Alibaba Health Information Technology Ltd <0241.HK>: Announcement of final results for the year ended March 31, 2016 <0241.HK> . Group recorded revenue of RMB56.6 million for year ended March 31, 2016, representing an increase of 90.3% . Says directors do not recommend the payment of a final dividend for the year ended March 31, 2016 . FY net loss attributable to owners of the parent amounted to RMB191.6 million, representing an increase of 135.9% .  Full Article

No consensus analysis data available.